Human Molecular Genetics Advance Access originally published online on June 2, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Human Molecular Genetics, 2004, Vol. 13, No. 15 1649-1656
DOI: 10.1093/hmg/ddh171
Human Molecular Genetics, Vol. 13, No. 15 © Oxford University Press 2004; all rights reserved
The transforming growth factor-ß1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD)
1Channing Laboratory and 6Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, 2Division of Pulmonary and Critical Care Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, 3Harvard Medical School, Boston, MA, USA, 4Department of Biostatistics, Harvard School of Public Health, Boston, MA, USA, 5Western Australian Institute for Medical Research, Centre for Medical Research, University of Western Australia, Perth, Australia and 7Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California at San Francisco, San Francisco, CA, USA
Received April 6, 2004; Accepted May 19, 2004
Although cigarette smoking is the primary environmental risk factor, genetic risk factors likely influence the development of chronic obstructive pulmonary disease (COPD). Linkage analysis between short-tandem repeat markers on chromosome 19 and COPD phenotypes was followed by association analysis of single nucleotide polymorphisms in a gene on chromosome 19q [transforming growth factor-ß1 (TGFB1)] and COPD phenotypes in a family-based sample and a casecontrol study (cases with severe COPD and control subjects with significant history of smoking but no COPD). Stratification by smoking status substantially improved the evidence of linkage to chromosome 19q for COPD phenotypes. Among former and current smokers in the Boston Early-Onset COPD Study, there was significant evidence of linkage between chromosome 19q and pre-bronchodilator (pre-BD) FEV1 (LOD=3.30) and suggestive evidence of linkage between chromosome 19q and other COPD phenotypes. In these families, a SNP in the promoter region of TGFB1 (rs2241712) and two SNPs in the 3' genomic region of TGFB1 (rs2241718 and rs6957) were significantly associated with pre- and post-BD FEV1 (P<0.05). Among smokers in the COPD cases and control subjects, two SNPs in the promoter region of TGFB1 (rs2241712 and rs1800469) and one SNP in exon 1 of TGFB1 (rs1982073) were significantly associated with COPD (P
0.02 in all cases). Chromosome 19q likely contains a genetic locus (or loci) that influences COPD through an interaction with cigarette smoking. We hypothesize that genetic variants in or near the TGFB1 gene influence the pathogenesis of COPD among cigarette smokers.
* To whom correspondence should be addressed at: Channing Laboratory, 181 Longwood Avenue, Boston, MA 02115, USA. Tel: +1 6175250856; Fax: +1 6175250958; Email: juan.celedon{at}channing.harvard.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. A. Bremer, S. M. Blackman, L. L. Vanscoy, K. E. McDougal, A. Bowers, K. M. Naughton, D. J. Cutler, and G. R. Cutting Interaction between a novel TGFB1 haplotype and CFTR genotype is associated with improved lung function in cystic fibrosis Hum. Mol. Genet., July 15, 2008; 17(14): 2228 - 2237. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zanini, A. Chetta, and D. Olivieri Review: Therapeutic perspectives in bronchial vascular remodeling in COPD Therapeutic Advances in Respiratory Disease, June 1, 2008; 2(3): 179 - 187. [Abstract] [PDF] |
||||
![]() |
C. P. Hersh, D. L. DeMeo, and E. K. Silverman National Emphysema Treatment Trial State of the Art: Genetics of Emphysema Proceedings of the ATS, May 1, 2008; 5(4): 486 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Brehm and J. C. Celedon Chronic Obstructive Pulmonary Disease in Hispanics Am. J. Respir. Crit. Care Med., March 1, 2008; 177(5): 473 - 478. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Collaco, L. Vanscoy, L. Bremer, K. McDougal, S. M. Blackman, A. Bowers, K. Naughton, J. Jennings, J. Ellen, and G. R. Cutting Interactions Between Secondhand Smoke and Genes That Affect Cystic Fibrosis Lung Disease JAMA, January 30, 2008; 299(4): 417 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. DeMeo, E. J. Campbell, A. F. Barker, M. L. Brantly, E. Eden, N. G. McElvaney, S. I. Rennard, R. A. Sandhaus, J. M. Stocks, J. K. Stoller, et al. IL10 Polymorphisms Are Associated with Airflow Obstruction in Severe {alpha}1-Antitrypsin Deficiency Am. J. Respir. Cell Mol. Biol., January 1, 2008; 38(1): 114 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Jonth, L. Silveira, T. E. Fingerlin, H. Sato, J. C. Luby, K. I. Welsh, C. S. Rose, L. S. Newman, R. M. du Bois, L. A. Maier, et al. TGF-beta1 Variants in Chronic Beryllium Disease and Sarcoidosis J. Immunol., September 15, 2007; 179(6): 4255 - 4262. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. DeMeo, C. P. Hersh, E. A. Hoffman, A. A. Litonjua, R. Lazarus, D. Sparrow, J. O. Benditt, G. Criner, B. Make, F. J. Martinez, et al. Genetic Determinants of Emphysema Distribution in the National Emphysema Treatment Trial Am. J. Respir. Crit. Care Med., July 1, 2007; 176(1): 42 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-R. Kang, C. G. Lee, R. J. Homer, and J. A. Elias Semaphorin 7A plays a critical role in TGF-{beta}1-induced pulmonary fibrosis J. Exp. Med., May 14, 2007; 204(5): 1083 - 1093. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Hersh, D. T. Miller, D. J. Kwiatkowski, and E. K. Silverman Genetic determinants of C-reactive protein in COPD Eur. Respir. J., December 1, 2006; 28(6): 1156 - 1162. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Beghe, E. Bazzan, S. Baraldo, F. Calabrese, F. Rea, M. Loy, P. Maestrelli, R. Zuin, L. M. Fabbri, and M. Saetta Transforming growth factor-{beta} type II receptor in pulmonary arteries of patients with very severe COPD Eur. Respir. J., September 1, 2006; 28(3): 556 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. O. C. Cookson State of the Art. Genetics and Genomics of Chronic Obstructive Pulmonary Disease Proceedings of the ATS, August 1, 2006; 3(6): 473 - 475. [Full Text] [PDF] |
||||
![]() |
E. K. Silverman Progress in chronic obstructive pulmonary disease genetics. Proceedings of the ATS, July 1, 2006; 3(5): 405 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Hersh, D. L. DeMeo, R. Lazarus, J. C. Celedon, B. A. Raby, J. O. Benditt, G. Criner, B. Make, F. J. Martinez, P. D. Scanlon, et al. Genetic Association Analysis of Functional Impairment in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., May 1, 2006; 173(9): 977 - 984. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Stanke, B. Tummler, T. Becker, G. Rossi, V. Rossi, M. Drumm, F. Wright, and M. Knowles Genetic Modifiers in Cystic Fibrosis N. Engl. J. Med., January 5, 2006; 354(1): 88 - 90. [Full Text] [PDF] |
||||
![]() |
S Baraldo, E Bazzan, G Turato, F Calabrese, B Beghe, A Papi, P Maestrelli, L M Fabbri, R Zuin, and M Saetta Decreased expression of TGF-{beta} type II receptor in bronchial glands of smokers with COPD Thorax, December 1, 2005; 60(12): 998 - 1002. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Drumm, M. W. Konstan, M. D. Schluchter, A. Handler, R. Pace, F. Zou, M. Zariwala, D. Fargo, A. Xu, J. M. Dunn, et al. Genetic Modifiers of Lung Disease in Cystic Fibrosis N. Engl. J. Med., October 6, 2005; 353(14): 1443 - 1453. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Haston and T. J. Hudson Finding Genetic Modifiers of Cystic Fibrosis N. Engl. J. Med., October 6, 2005; 353(14): 1509 - 1511. [Full Text] [PDF] |
||||
![]() |
C. P. Hersh, D. L. DeMeo, C. Lange, A. A. Litonjua, J. J. Reilly, D. Kwiatkowski, N. Laird, J. S. Sylvia, D. Sparrow, F. E. Speizer, et al. Attempted Replication of Reported Chronic Obstructive Pulmonary Disease Candidate Gene Associations Am. J. Respir. Cell Mol. Biol., July 1, 2005; 33(1): 71 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. DeMeo, J. C. Celedon, C. Lange, J. J. Reilly, H. A. Chapman, J. S. Sylvia, F. E. Speizer, S. T. Weiss, and E. K. Silverman Genome-wide Linkage of Forced Mid-expiratory Flow in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., December 15, 2004; 170(12): 1294 - 1301. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Johnson Which smokers will acquire COPD? Thorax, November 1, 2004; 59(11): 965 - 965. [Full Text] [PDF] |
||||










